9
Participants
Start Date
July 5, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Remunity Pump for Remodulin
Participants on the study will receive Remodulin via the Remunity Pump with dosing and titration managed at the discretion of the prescribing healthcare professional. Dosing and titration of Remodulin will in no way be influenced by the participation in this study or this protocol.
Syneos Health, Morrisville
Lead Sponsor
United Therapeutics
INDUSTRY